granisetron has been researched along with Uterine Neoplasms in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (80.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukunaka, N; Ishioka, S; Kobayashi, K; Kudo, R; Minami, M; Nishioka, Y; Sagae, S; Sugimura, M; Terasawa, K | 1 |
Eguchi, F; Emoto, M; Hachisuga, T; Kawarabayashi, T; Mohtai, H; Shindo, M; Shirakawa, K | 1 |
Fujii, T; Kioka, H; Naito, H; Nakagawa, H; Nakata, N; Tanimoto, H; Tanioka, Y | 1 |
Fukunaka, N; Ishioka, S; Itoh, E; Kitajima, Y; Kudo, R; Sagae, S; Sato, K | 1 |
Kitada, M; Sawaragi, I | 1 |
Akutagawa, N; Fukunaka, N; Hayashi, T; Kitajima, Y; Kudo, R; Mizumoto, H; Nakamura, T; Sagae, S; Sugimura, M; Terasawa, K; Wataba, K; Yamana, K | 1 |
Aoki, Y; Endo, M; Furue, H; Hanaoka, J; Honma, S; Kodama, S; Maruhashi, T; Oshima, T; Takahashi, T; Takeuchi, Y; Tanaka, K; Tokunaga, A; Yoshiya, N | 1 |
Fujimori, R; Sanada, H; Sekine, M; Serikawa, T; Shichiri, K; Tanaka, K | 1 |
Fujiwara, K; Ishikawa, H; Kohno, I; Nagaji, M; Suzuki, S; Yamauchi, H | 1 |
Nakayama, S; Noda, T; Torii, Y | 1 |
9 trial(s) available for granisetron and Uterine Neoplasms
Article | Year |
---|---|
Combination therapy with granisetron, methylprednisolone and droperidol as an antiemetic prophylaxis in CDDP-induced delayed emesis for gynecologic cancer.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Droperidol; Drug Therapy, Combination; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Premedication; Uterine Neoplasms; Vomiting | 2003 |
[The prevention of cancer chemotherapy-induced emesis with granisetron and clonazepam].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clonazepam; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Nausea; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting | 1995 |
[Antiemetic efficacy of the repeated use of granisetron in multiple cycles of anti-cancer chemotherapy].
Topics: Carboplatin; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting | 1994 |
[Clinical evaluation of granisetron hydrochloride against nausea and vomiting induced by anticancer drugs for gynecological malignant tumors].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1996 |
[A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Droperidol; Drug Administration Schedule; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1997 |
[Clinical evaluation of 2-mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Tablets; Uterine Neoplasms; Vomiting | 1997 |
[Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1998 |
[Optimal timing of granisetron administration for the prevention of carboplatin-induced acute emesis].
Topics: Acute Disease; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Middle Aged; Nausea; Ovarian Neoplasms; Pilot Projects; Prospective Studies; Time Factors; Uterine Neoplasms; Vomiting, Anticipatory | 1999 |
[Evaluation of efficacy of ramosetron orally disintegrating tablets and patient preference as to the dosage form in gynecological cancer chemotherapy].
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Endometrial Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Serotonin Antagonists; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting, Anticipatory | 2001 |
1 other study(ies) available for granisetron and Uterine Neoplasms
Article | Year |
---|---|
[The prevention of CDDP-induced emesis with granisetron].
Topics: Antiemetics; Cisplatin; Female; Granisetron; Humans; Indazoles; Infusions, Intravenous; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1993 |